期刊文献+

脑梗死合并代谢综合征与脑动脉粥样硬化性狭窄的关系 被引量:2

Relationship between cerebral artery atherosclerotic stenosis and metabolic syndrome in patients with acute cerebral infarction
原文传递
导出
摘要 目的探讨代谢综合征(MS)与脑动脉粥样硬化性病变的相关性。方法对74例因急性脑梗死入院的患者分为MS组(40例)及非MS组(34例)。借助经颅多普勒超声和(或)磁共振血管成像比较两组颅内外动脉粥样硬化性狭窄发生率。结果 MS组血管狭窄发生率为85.0%,明显高于非MS组的64.7%(P<0.05)。多元logistic回归分析示,MS与动脉粥样硬化无独立相关性,高密度脂蛋白胆固醇(HDL-C)与动脉粥样硬化独立相关(OR=0.071)。结论 MS与脑动脉粥样硬化性狭窄相关,但其危险性依赖于MS组中的低HDL-C血症。 Objective To investigate the correlation of metabolic syndrome(MS) and atherosclerotic stenosis in patients with acute cerebral infarction(ACI).Methods A total of 74 patients with ACI was divided into MS group(40 cases) and non-MS group(34 cases).The incidences of intra-and extra-cranial atherosclerotic stenosis were measured with transcranical Doppler(TCD) and magnetic resonance angiography(MRA).Results The incidence of atherosclerotic stenosis was higher in MS group than that in non-MS group(85.0% vs.64.7%)(P〈0.05).Multiple logistic regression analysis indicated that the decreased HDL-C,but not the presense of MS,was an independent risk factor for cerebrovascular stenosis(OR=0.071).Conclusion MS is associated with atherosclerotic stenosis and the drop of HDL-C is an independent risk factor in MS patients with ACI.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第18期2137-2139,共3页 Jiangsu Medical Journal
关键词 代谢综合征 急性脑梗死 脑动脉粥样硬化 Metabolic syndrome Acute cerebral infarction Cerebral atherosclerotic stenosis
  • 相关文献

参考文献10

  • 1Ninomiya JK, L'ltalian G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infraction and stroke in the Third National Health and Nutrition Examination Survey[J]. Circulation, 2004,109 (1) : 42-46.
  • 2Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam[J]. Diabetes Care, 2002,25 (10) : 1790-1794.
  • 3Isomaa B,Aimgren P,Tuomi T,et al. Cardiovascular morbid- ity and mortality associated with the metabolic syndrome[J]. Diabetes Care, 2001,24(4) : 683-689.
  • 4Wong KS, Huang YN, Gao S, et al. Intracranial stenosis in Chinese patients with acute stroke[J]. Neurology, 1998, 50 (3) :812-813.
  • 5Gimeno Orna JA, Lou Arnal LM, Molinero Herguedas E, et al. Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes[J]. Rev Esp Cardiol, 2004, 57 (6) :507-513.
  • 6Kurl S,Laukkanen JA,Niskanen L,et al. Metabolic syndrome and the risk of stroke in middle-aged men[J]. Stroke,2006,37 (3):806-811.
  • 7Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines[J]. Circulation, 2004,110(2) : 227-239.
  • 8Avogaro A, Fadini GP, Gallo A, et al. Endothelial dysfunction in type 2 diabetes mellitus[J]. Nutr Metab Cardiovasc Dis, 2006,16 (Suppl 1) :39-45.
  • 9Haidara MA, Yassin HZ, Rateb M, et al. Role of oxidative stress in development of cardiovascular complicdtions in diabetes mellitus[J]. Curr Vasc Pharmacol, 2006,4 (3) : 215- 217.
  • 10高璐,于德民.马来酸罗格列酮对非糖尿病代谢综合征患者糖脂代谢及炎症的影响[J].江苏医药,2007,33(11):1117-1118. 被引量:2

二级参考文献5

  • 1Chen J, Wildman RP, Harem LL, et al. Association between inflammation and insulin resistance in U. S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey [J]. Diabetes Care , 2004,27(12):2960- 2965.
  • 2Diani AR, Sawada G, Wyse B, et al. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes [J].Am J Physiol Endocrinol Metab, 2004,286(1): E116-E122.
  • 3bIull RL, Shen ZP, Watts MR, et al. Long term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide [J]. Diabetes, 2005, 54(7) :2235-2244.
  • 4Kim SG, Ryu OH, Kim HY, et al. Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or non-diabetic metabolic syndrome [ J ]. Eur J Endocrinol, 2006,154(3) : 433-440.
  • 5Mohanty P,Aljada A,Ghanim H, et al. Evidence for a potent antiinflammatory effect of rosiglitazone[J]. J Clin Endoerinol Metab, 2004, 89(6): 2728 - 2735.

共引文献1

同被引文献16

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部